How does Pfizer's expense management compare year-over-year?

Pfizer's expense management shows a significant focus on research and development, with $3.04 billion in R&D expenses in the most recent quarter. However, the company's total operating expenses, which include SG&A and marketing expenses, are not currently available. To assess expense management year-over-year, it's important to consider the total operating expenses and compare them with the total revenue, which stands at $17.76 billion for the same period.

|code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code|
|---|---|---|---|---|---|---|
|PFE|PFE.N|Pfizer|2024 Q1|-19.51206318294926|1.4879E10|169|
|PFE|PFE.N|Pfizer|2024 Q2|2.121934343046052|1.3283E10|169|
|PFE|PFE.N|Pfizer|2024 Q3|31.21340152694389|1.7702E10|169|
|PFE|PFE.N|Pfizer|2024 Q4|21.914893617021278|1.7763E10|169|

|code|Ticker|Name|Date|R&D Expenses|Advertising and Marketing Expenses|market_code|
|---|---|---|---|---|---|---|
|PFE|PFE.N|Pfizer|2024 Q1|2.493E9||169|
|PFE|PFE.N|Pfizer|2024 Q2|2.696E9||169|
|PFE|PFE.N|Pfizer|2024 Q3|2.598E9||169|
|PFE|PFE.N|Pfizer|2024 Q4|3.035E9||169|